amrinone has been researched along with Heart Valve Diseases in 6 studies
Amrinone: A positive inotropic cardiotonic (CARDIOTONIC AGENTS) with vasodilator properties, phosphodiesterase 3 inhibitory activity, and the ability to stimulate calcium ion influx into the cardiac cell.
amrinone : A 3,4'-bipyridine substituted at positions 5 and 6 by an amino group and a keto function respectively. A pyridine phosphodiesterase 3 inhibitor, it is a drug that may improve the prognosis in patients with congestive heart failure.
Heart Valve Diseases: Pathological conditions involving any of the various HEART VALVES and the associated structures (PAPILLARY MUSCLES and CHORDAE TENDINEAE).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (50.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Xiao, X | 1 |
| Luo, C | 1 |
| Zhuang, X | 1 |
| Yin, D | 1 |
| Chen, Y | 1 |
| Cao, G | 1 |
| Huang, X | 1 |
| Tian, Z | 1 |
| Shi, Y | 1 |
| Wilmshurst, PT | 1 |
| Walker, JM | 1 |
| Fry, CH | 1 |
| Mounsey, JP | 1 |
| Twort, CH | 1 |
| Williams, BT | 1 |
| Davies, MJ | 1 |
| Webb-Peploe, MM | 1 |
| Jenkins, IR | 1 |
| Dolman, J | 1 |
| O'Connor, JP | 1 |
| Ansley, DM | 1 |
| Sha, K | 1 |
| Shimokawa, M | 1 |
| Ishimaru, K | 1 |
| Kawaraguchi, Y | 1 |
| Takahashi, M | 1 |
| Yanaidani, F | 1 |
| Kitaguchi, K | 1 |
| Furuya, H | 1 |
| Günnicker, M | 1 |
| Hess, W | 1 |
| MacGillivray, RG | 1 |
| Crause, L | 1 |
| Odell, JA | 1 |
| Rozwadowski, MA | 1 |
3 trials available for amrinone and Heart Valve Diseases
| Article | Year |
|---|---|
[Randomized controlled trial for the effect of amrinone and aprotinin on proinflammatory cytokine release in patients with prosthetic valve replacement during perioperative period].
Topics: Adult; Amrinone; Aprotinin; Cardiopulmonary Bypass; Cardiotonic Agents; Heart Valve Diseases; Heart | 2001 |
Amrinone versus dobutamine in cardiac surgical patients with severe pulmonary hypertension after cardiopulmonary bypass: a prospective, randomized double-blinded trial.
Topics: Amrinone; Cardiopulmonary Bypass; Cardiotonic Agents; Dobutamine; Double-Blind Method; Female; Heart | 1997 |
[Differences in hemodynamic effects of amrinone, milrinone and olprinon after cardiopulmonary bypass in valvular cardiac surgery].
Topics: Aged; Amrinone; Cardiopulmonary Bypass; Female; Heart Valve Diseases; Hemodynamics; Humans; Imidazol | 2000 |
3 other studies available for amrinone and Heart Valve Diseases
| Article | Year |
|---|---|
Inotropic and vasodilator effects of amrinone on isolated human tissue.
Topics: Aminopyridines; Amrinone; Animals; Cardiotonic Agents; Dose-Response Relationship, Drug; Female; Gui | 1984 |
Preliminary results with amrinone in perioperative low cardiac output syndrome.
Topics: Aged; Amrinone; Cardiac Output, Low; Coronary Artery Bypass; Dose-Response Relationship, Drug; Femal | 1987 |
Amrinone after cardiopulmonary bypass surgery. A case report.
Topics: Adult; Aminopyridines; Amrinone; Aortic Valve; Blood Pressure; Cardiopulmonary Bypass; Cardiotonic A | 1985 |